BioTech Magazine readers are from the research labs / educational institutes/university, the clinical research, policy makers, Consultants, Fund managers, Key executives and the influencers in pharmaceutical / agricultural companies, clinical trials and contract manufacturing organizations and other sectors.

Contact:
Editor
editor at btmag dot co dot in

General Inquiry
info at btmag dot co dot in

http://rbc.btmag.co.in                          (Rohini BioTech Consultant, RBC)
http://www.btmag.co.in                        (BioTech Magazine, Free Version for All)
http://nanotech.btmag.co.in                    (NanoTech Magazine, India’s First NanoTech Magazine)
http://skmindia.btmag.co.in                    (SKMIndia, World’s First Complete database on BioTech Information)

farms, farmers and farming

we want to include several topics (html) about:  agriculture versus biotechnogy

this to show the farmers and our readers/viewers the importance of present biotechnology,

there fore we ask your assistance

please advise good articles (html)

our website is interactive, so the visitor can ask, via email, information about a
specific topic or theme.  so, the contents of the site changes daily and fast

have a look at   http://www.farmersbase.com

and keep us posted

Happy Easter days

farmersbase / netherlands

Synopsis and overview of the Book is available at the University press:

http://www.ctuniv.org/university-press.htm

About the Book:
Soft cover
282 pages with 70 colour images, illustrations and tables.

The book is based on Bio-MBA lectures, invited seminar series organized by Japan External Trade Organization (JETRO) and hands-on experience in developing biotech businesses from academic to industry.

Biopreneurs, from the title on is well-structured into four main sections. The reader is smoothly driven in a dynamic and convincing way to understand the interactions of the scientific aspects of biotechnology with legal, political, regulatory and even ethical approaches required to make biotechnology a commercial success.

Indeed, the opening chapters introduce readers to the real concept of applied biotechnology, defined not only as a product or service making one, but also as a mixture of technologies that altogether and in harmony allow the development of a long-lasting commercial biotechnology.

Particularly noticeable is the clarifying chapters on various issues and the differentiation between the intertwined concepts normally associated with the issue of intellectual property. Next, the author dives the reader into corporate biotechnology, highlighting the requirements to establish a biotechnology company.

Content -
Ch I:  Entrepreneurship in Biotechnology
Ch II:  Biopreneurs
Ch III: Understanding the Business of Biotechnology
Ch IV:  Pre-clinical Development
Ch V:  Clinical Development
Ch VI:  Beginning a Bioventure
Ch VII:    Funding for Bioventure
Ch VIII:  Fund Raising   Ch IX:  Valuation
Ch X:  Public Relations & Investor Relations
Ch XI:  Role of Marketing in Biotech Business
Ch XII:    Investment in Biotech Industry
Ch XIII:  Journey of a Biopreneur
Ch XVI:  It’s your Call
Cha XV:  Success
Supplements
—————————————-

Biopreneurs: The Molecular Millionaires is a robust, commercially-oriented readable book that should be read not only by specialists, but also by entrepreneurs who foresee Biotechnology as the business of tomorrow.

With over one billion inhabitants and one of the largest and fastest growing markets in the world, India clearly offers a vast number of opportunities for EU enterprises and science and technology (S&T) entities.

In particular, India is emerging as a biotechnology powerhouse in Asia. Aside from great opportunities presented by the huge internal market, it also features a fast growing number of Science Parks, competitive companies and excellent University Institutes. Hyderabad and Bangalore are two internationally recognized centres of research and business in biotech.

However, European SMEs have various barriers for the access to Indian Biotech market: access to finance is easier said than done and the Indian system as a whole is very complex due to lack of information on legal and ethical issues. For example, one serious obstacle to business and investments in the region is a lack of information on IPR in India.

On the other hand, India is also one of the world’s worst polluters and faces catastrophic impacts from climate change. To secure sustainable development, the country must therefore identify areas in its booming economy where clean technology can be used. India will have to “reinvent growth” without polluting heavily.

Conversely, European expertise in clean technologies and the extensive worldwide efforts to combat climate change represent a major economic opportunity. This is where a close cooperation between the European and Indian communities can make a difference and have an important impact, notably in the green and white biotech.

On the EU - India summit in Marseille in 2009, leaders stressed that climate change is one of the biggest challenges of our time and therefore decided that clean and sustainable development should be a joint priority area of EU-India cooperation.

An European Business and Technology Centre in India

In this context, 16 European partners under the overall coordination of Eurochambres, the Association of European Chamber of Commerce and Industry, have recently established the European Business and Technology Centre within a European Union co-funded program. The Centre is already operative in New Delhi and other local offices will be established soon.

The idea of EBTC is to reconcile two objectives: addressing climate change challenges in India and assisting businesses, research institutions as well as individual researchers - in Europe and India - to work together towards generating and enhancing business opportunities and technology transfer.
Moreover, the Centre aims to become one of the main reference points for promoting European business and research in India.

The Centre will provide support services to EU companies and researchers eager to enter the Indian market, with a focus on technologies related to climate change in 4 selected key sectors: Biotechnology, Energy, Environment and Transport.

The Milan Chamber of Commerce, coordinator of the biotech cluster within the consortium, with two other European leading regional biotechnology industry groups as ERBI from Cambridge and COPCA from Barcelona, will implement a number of activities to overcome described obstacles and foster a durable EU-India cooperation in business as well as in research projects.

Biotech activities

To overcome the lack of information and knowledge about Indian biotech market and about funding and business opportunities in both European and Indian realities, partners will set an information service. This activity aims to enhance transparency of market access conditions in India and empowering European companies, research institutions as well as individual researchers with cutting edge intelligence on opportunities in the Indian market. Many existing initiatives and networks already generate knowledge and information on the Indian market. EBTC is centralising this existing knowledge and making sure it becomes more accessible to the European Business and Research Community.

Once a general frame of the industrial and research state of the art will be acquired, and a map of possibilities and opportunities will be available, partners will stimulate cooperation through networking actions and matchmaking events.
In this purpose, the consortium will organize several events to present biotech opportunities with the involvement of key actors from both research and business to enhance potential cooperation with Indian companies. It will also take part to main biotech events in Europe as well as in India to promote EBTC activities.

Consortium partners will also be engaged in facilitating the cooperation between European and Indian companies, research institutions and individual researchers in specific, well-defined fields. This includes promoting the participation of EU researchers in Indian funded programs, subsector-specific matchmaking events, development and implementation of best-practice case studies, organisation of trade missions in cooperation with the European Member States etc.

In addiction, through a structured networking approach, EBTC intends to make a valuable contribution to EU-India relations through establishing a dialogue with political decision makers, interacting with public authorities, R&D organizations, cluster / sub cluster consultative groups and private players. Effective networking will be done in order to establish productive long-term relationships. Consortium partners will participate in seminars and workshops of key associations to discuss relevant trade aspects and collect information.

If you are interested in opportunity raised from EBTC, don’t hesitate to get in contact with us:

Gianpaolo Sarolli: sarolli dot gianpaolo at mi dot camcom dot it ; +39 02 8515 5234
Ilaria Bonetti: bonetti dot ilaria at mi dot camcom dot it; +39 02 8515 5230
Marina Calcagno: calcagno dot innovhub at mi dot camcom dot it; +39 02 8515 5364

We are looking forward to collaborate with you.

http://www.biopreneur.org/images/Biopreneur_N1V2.pdf

It is taking longer than usual to download, so please allow some moment. 
Previous issue also can be found at

http://www.biopreneur.org/download-e.htm

Thank you,
RYAN Baidya

California Takshila University
Biopreneur

The Bio Technology Park envisages creation of state of art, infrastructure suitable for the Bio Technology Industry covering a wide range of activities as listed in Annexure “A”.  Apart from state of art infrastructure as listed in Annexure “B”, we are also building a state of art incubation centre measuring over 86,000 sq. ft.  The incubation centre will have all the facilities that will enable technocrats, startup companies and other entrepreneurs to avail these facilities in order to standardize and scale-up processes and thereafter, set up their own enterprise in the park.  The incubation center will be ready in the year 2008. 

Apart from the incubation centre, the layout of the park will include developed plots of various sizes ranging from 8,000 sq. mtr.  To 2,00,000 sq. mtr.  All these plots will have access to advanced utilities and support facilities as listed in Annexure “C”.  In order to create the right ambience, there will be wide landscaping covering large areas of the park.  We are also setting aside a portion of the park for creating a residential zone and lifestyle amenities so that the entire park is developed into a mini townships to match the lifestyle and the requirements of the knowledge workers in the Bio Tech Industry.
The company being the JV with the Gujarat Government enjoys the patronage of Gujarat Government through a liberal Bio Technology Policy and the progressive administrative set up of the Government. 

We also seek to actively collaborate with Educational and Research Institutes in an attempt to integrate the various stakeholders and to provide the park a multi dimensional outlook.

In this respect kindly revert back with your interest, on any information that you may require by emailing to us on biotech at akruticity dot com.

Our website- http://www.akrutibiotech.com

This issue covers
IP-management in the life-sciences industry ** Stem-cell and cancer, **Biopreneur-the basics- Bio-businesses in and around Asia India-Japan-China .. and so on…

About Bioprenur:
Biopreneur is a consortium established by Dr. Ryan Baidya, a career entrepreneur, who coined the term biopreneur in 1998.  Later he made the term more familiarize through his yearlong column in a magazine Called Bioventure, published in Tokyo.

Biopreneur is for the people who wish to learn more about biotech business, start their own, increase their wealth by investing in biotech business and simply enjoy being part of a highly intellect driven industry. 

Biopreneur provides coaching and counseling to the entrepreneurs who wish to start their own bio-business.  Biopreneur also offers critical strategic business development support to the biotech businesses in USA and Japan. 

Goal
Develop a platform where freshmen and seasoned biopreneurs communicate and shares their knowledge and wisdom that they have learned hands-on.
Develop means for the individual and institutional investors have access to true understanding of triple-bottom line return concept and opportunities that a biotech business can offer for their life and their grand children lives.
Develop training, and mentoring programs by the biopreneurs for the biopreneurs.
Develop mechanism to work with economic development agencies for local and global economic-equity and human health.
Biopreneur serves as a focal point for bringing together scientists, businesspeople and investors and plays a major role .in promoting the education and training of people with biotech zeal.

deepak p.phadtare
msc (agril) plant pathology
deepak dot phadtare at gmail dot com
cell number : +919923165830

Kind Regards,

Pulkit Sharma